Yeah, I just read this on the annual report
Seqirus sales of US$652 million reflect 11 months of sales since
the acquisition of Novartis’ influenza vaccines business on 31
July 2015. Sales of influenza vaccine were adversely impacted by
a mild influenza season in the northern hemisphere. The Seqirus
business turnaround program remains on track.
Yeah, I just read this on the annual report Seqirus sales of...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$296.95 |
Change
-2.805(0.94%) |
Mkt cap ! $143.4B | |||
| Open | High | Low | Value | Volume |
| $299.64 | $300.03 | $296.06 | $70.83M | 237.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 78 | $296.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $296.97 | 9 | 1 |
View Market Depth
| Last trade - 13.04pm 08/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |